CSafe Global Announces Acquisition of Softbox Systems to Create the Global Leader in Temperature-Controlled Shipping Solutions

CSafe Global Announces Acquisition of Softbox Systems to Create the Global Leader in Temperature-Controlled Shipping Solutions

[DAYTON, Ohio, US and LONG CRENDON, Buckinghamshire, UK], December 15, 2021 – CSafe Global, the leader in temperature-controlled container solutions for the pharmaceutical industry, announced today that it has acquired Softbox Systems, a provider of passive temperature-controlled packaging solutions for the pharmaceutical, life science and cold chain logistics industries, significantly enhancing CSafe’s passive product portfolio. Together, they will provide the most comprehensive suite of thermal shipping solutions and become a one-stop-shop for all pharmaceutical cold chain shipping needs, enabling delivery of critical temperature-sensitive products, including next generation biologics, cell and gene therapy, and mRNA therapies such as the COVID-19 vaccine.

The combined company, which will operate globally under the CSafe brand, will be the only cold chain platform with an end-to-end active air cargo and passive temperature-controlled packaging business spanning the complete spectrum of cold chain shipping solutions for the pharmaceutical and life sciences industries. Softbox’s well-regarded brands in the passive container space, such as SilverSkin, Silverpod and Tempcell, complement CSafe’s leading active product portfolio, particularly within air cargo. The acquisition will unlock opportunities for innovation as well as enhance CSafe’s sustainable and eco-friendly offerings, with new reusable and recyclable pallet and parcel solutions.

Around the globe, a large industry pipeline of life-saving pharmaceutical therapies with strict temperature profiles is accelerating the need for reliable, temperature-controlled shipping solutions. Moreover, future pharmaceutical advances will require a new generation of qualified fit-for-purpose packaging, along with sophisticated tracking technology, that also helps customers meet their sustainability and recycling goals.

“Through this combination, we will be the partner of choice for cold chain delivery of high value, temperature sensitive pharmaceutical therapies. Both CSafe and Softbox have proven to be reliable partners for customers seeking a secure way to deliver their life-enhancing products around the world,” said Patrick Schafer, CSafe CEO. “We’re thrilled to now offer our customers a platform that provides everything from the highest quality packaging to AI-enabled thermal and kinetic monitoring and logistics management.”

“Our businesses are each rooted in a commitment to excellent customer service and high product quality, which made this combination a natural fit,” said Kevin Valentine, CEO of Softbox. “Together we will proudly continue to partner with our global Pharmaceutical customers to devise and deliver the best solutions for their evolving cold chain shipping needs, supporting the delivery of temperature sensitive lifesaving medicines and vaccines.

“With the addition of Softbox’s product portfolio, CSafe strengthens its global infrastructure across air and ground while expanding its offerings for parcel delivery, all supported by the most advanced technology infrastructure,” said Todd Abbrecht, Co-CEO of Thomas H. Lee Partners, which first invested in CSafe in 2016. “We see an incredible opportunity for the combined company to serve as the international partner of choice for cold chain shipping solutions and remain on the forefront of innovation in the industry.”

“The acquisition of Softbox advances CSafe’s strategy to be the leading cold chain solutions provider with a full suite of products and services to meet the needs of its pharmaceutical customers around the globe,” said Ben Magnano, Co-Managing Partner of Frazier Healthcare Partners. “CSafe is an excellent platform to build upon and we, alongside our partners at THL, will continue to make investments to further strengthen the Company’s leadership position in pharmaceutical cold chain.”

As part of the acquisition, Softbox CEO Kevin Valentine will assume the role of president of CSafe’s Passive Temperature Controlled Packaging Division.

Terms of the transaction were not disclosed.

Media Contact:
For CSafe Global and Softbox Systems:
Lori Conaway
+1 405.633.2344
lconaway@csafeglobal.com

About CSafe Global
CSafe Global provides end-to-end thermal shipping solutions to the pharmaceutical and life science industries worldwide. An industry innovator, CSafe is the only provider of both active and passive solutions and offers AI-enabled lease forecasting to ensure active container availability and real-time shipment visibility for active and passive containers. CSafe provides industry-leading maintenance and reuse programs ensuring superior product performance and alignment with customer sustainability objectives. With a presence in 150 countries, 24/7 support and 100% container availability, CSafe is well-positioned to be the partner of choice in the cold chain. csafeglobal.com

About Softbox
Softbox is an award-winning temperature control packaging innovator that has been designing and producing high performance passive temperature control packaging solutions for over 25 years. We offer consistent quality to our clients from our strategically located global manufacturing sites throughout Europe, Americas, India and Asia Pacific.

We have formed long standing partnerships with the world’s leading pharmaceutical, clinical research, biotech and logistics companies, and apply innovative thinking to overcome the challenges that our clients face in managing the Cold Chain when shipping temperature sensitive clinical trial and commercialised products.

For more information about Softbox, visit www.softboxsystems.com

About Thomas H. Lee Partners
Thomas H. Lee Partners, L.P. (“THL”) is a premier private equity firm investing in middle-market growth companies exclusively in three sectors: Financial Services, Healthcare, and Technology & Business Solutions. THL couples deep sector expertise through our Identified Sector Opportunity (“ISO”) process with dedicated internal operating resources from our Strategic Resource Group (“SRG”) to transform and build great companies of lasting value in partnership with management. The Firm’s domain expertise and resources help to build great companies with an aim to accelerate growth, improve operations and drive long-term sustainable value. Since 1974, THL has raised more than $30 billion of equity capital, invested in over 160 companies and completed more than 500 add-on acquisitions representing an aggregate enterprise value at acquisition of over $210 billion. For more information, please visit www.thl.com.

SilverSkin announces new brand identity

SilverSkin announces new brand identity

The Complete Makeover

Over the last three years, the Softbox Group has incorporated every aspect of SilverSkin™ into the DNA of the company – with a great deal of success. While we are still the same people, producing the same reliable covers you expect, we are continuously striving for improvement, and we want the face of the company to reflect this.

Evolving and integrating the SilverSkin™ brand design is the final piece of the jigsaw.

We are proud to announce the launch of a new SilverSkin™ logo. Here’s an animation of how it has evolved over time!

Meet TP3 Global at the Temperature Controlled Logistics conference 2018 in Twickenham, London (IQPC)

Meet TP3 Global at the Temperature Controlled Logistics conference 2018 in Twickenham, London (IQPC)

Meet TP3 Global and Q-Products at our stand, conveniently located to the right of the entrance, stand #1.

Learn more about our solutions and discuss your specific requirements with Dharmesh Chauhan, Shane O’Shaughnessy, Kevin Valentine of TP3 Global and Paul Yadron of QPS.

Here is a few things to look forward to in the new year:

  • The SilverQuilt, released last November, is an innovative solution that delivers market leading performance for the crucial temperature range of 15-25°C. Both the roll and Pre-formed versions will be available for inspection and review at our stand.
  • Ask us about our in-house state of the art technical centre, now open to assist you in finding the best solution for your products. Equipped with a range of environmental, conditioning, and stress test chambers as well as industry leading simulation software, our technical centre delivers fast and accurate measurements in tests between temperatures as low as -40°C up to as high as 60°C.
  • The game changing Pallet Quilt, which is shipped-vacuum sealed, delivering more covers per pallet than ever before, further reducing costs of storage and shipping without compromising performance.

About the Temperature Controlled Logistics event:

The Temperature Controlled Logistics conference is one of the premiere events of the year for temperature sensitive shipments. Year after year the event sees more success, as attendees network and develop business relations.

 

You can read more in detail about the event at: temperaturecontrolledlogistics.com

TP3 Global Attending SMI Cold Chain London

TP3 Global Attending SMI Cold Chain London

SMi Group is to present the 12th annual industry leading summit on Cold Chain Distribution taking place on 13th & 14th December 2017 in Central London.

There has been a recent surge in temperature sensitive products entering the supply chain and the need for a streamlined temperature controlled supply chain has never been more important. Cold Chain Distribution 2017 looks at why companies must revisit their logistics, quality, and security procedures implemented to ensure they are keeping pace with this exponential growth.

The event will look at the fundamental question of how to keep costs low & quality high, while remaining compliant to global regulations?

Key topics for 2017 include:

– GPS temperature monitoring
– Temperature data management
– Temperature controlled freight options
– GDP Regulatory Requirements

TP3 Global is excited to be exhibiting at the conference on December 13/14th. We’ve seen this event grow and mature over the years so are looking forward to attending the education program, meeting with existing and potential new customers and to catching up with colleagues and friends within the cold chain industry. On display will be the newly released SilverQuilt, available in roll, kit or pre-formed cover formats, used to protect 15-25C CRT (controlled room temperature) pharmaceutical freight.

https://www.smi-online.co.uk/

SilverQuilt: Next generation thermal protection for temperature-sensitive cargo

SilverQuilt: Next generation thermal protection for temperature-sensitive cargo

The SilverQuilt™ achieves superior temperature protection for valuable, sensitive cargo, such as controlled room temperature (15°C to 25°C) pharmaceuticals, due to its specialist composition of multi-layered materials, and is able to protect freight within predefined temperature limits for extended periods during breaks within controlled supply chain lanes. SilverQuilt’s enhanced performance can provide protection for both +15°C to +25°C and +2°C to +8°C pharmaceutical products.

SilverQuilt’s unique construction insulates all areas of the pallet effectively, particularly areas that are at the highest risk of rapid temperature change, such as edges and corners. Its highly reflective outer skin protects against rapid temperature build up when in direct sunlight, extending the protection time when on the tarmac. The superior thermal protection provided by SilverQuilt’s layered construction also extends the periods of protection against cold ambient conditions.

In addition to providing quality thermal protection with reduced temperature exchange, SilverQuilt™ is water resistant and provides resistance against theft. It can also be shipped and delivered cost-effectively due to its compressible design.

Peter Lockett, director at TP3 Global, said: “Breaks in the cold chain are a serious issue for the pharmaceutical supply chain, with valuable stock often sitting on the tarmac for hours at a time. With the introduction of SilverQuilt™, pharmaceutical manufacturers can take a balanced approach, matching cost-effective protection with well managed supply chains.” 

Prior to its launch, SilverQuilt™ underwent testing as part of an extensive research and development process at TP3 Global’s advanced technical centre in Redditch, UK. The material was subjected to hot and cold environmental chamber testing, virtual cold chain simulation and thermal resistance (or R-value) testing. The test data, which was compiled by TP3 Global’s team of packaging technologists, will now be available to customers who undertake a risk-based approach in order to comply with Good Distribution Practice (GDP).

SilverQuilt™ joins TP3 Global’s existing range of qualified thermal protective covers, including SilverSkin™, a range of single-use covers primarily used during air, land and ocean freight.

Peter continued: “Our existing products, such as SilverSkin™, have achieved a solid reputation in the market, being tested, approved and now used by many of the worlds leading pharmaceutical manufacturers. SilverQuilt™ is the next logical step to support customers looking to protect controlled room temperature (CRT) freight with a high-performance cover solution with tighter control limits of +15°C to +25°C. The higher performance enables customers to consider the combination

of controlled lanes and thermal covers for +2°C to +8°C shipments, which was not possible with lower performance thermal covers.

With logistics providers improving the quality of controlled supply chain lanes, there are more options to utilise more cost effective thermal protection on palletised cargo.”

“The launch of SilverQuilt™ arrives at an exciting time for our business, as we continue global expansion and further establish ourselves as one of the leading providers of thermal protection solutions.

“The additional launch of the TP3 Technical Centre this year has increased our capacity to test materials beyond the identification of an R-value. The data this facility provides will support customer decisions on which insulation materials suit certain lanes, support them in taking a risk-based approach towards GDP and provide documented evidence for quality assurance and best practice.” 

Pharma supply chain specifiers urged to look beyond ‘R Values’ to measure thermal protection

Pharma supply chain specifiers urged to look beyond ‘R Values’ to measure thermal protection

Specifiers working in the pharmaceutical supply chain have been urged to ‘look beyond R values’ when specifying thermal protection solutions.

The advice, from TP3 Global, one of the world’s leading suppliers of thermal pallet cover solutions, is designed to help specifiers make informed choices in the absence of any formal industry standards for thermal protection solutions.

The continued increase in the availability of temperature-controlled distribution lanes within the global pharmaceutical supply chain has seen a corresponding growth in thermal protection solutions in recent years. Thermal protection covers are viewed by many in the pharma supply chain as a more cost-effective option compared to temperature controlled packaging and a viable way of mitigating the effects of inevitable ‘breaks’ within controlled lanes.

However, whilst the development and qualification of temperature-controlled packaging solutions has robust and recognised standards to which specifiers can refer, such standards for thermal protection solutions have not yet been developed, which makes comparison between different products difficult.

Kevin Valentine, Chief Technical Officer at TP3 Global, says that specifiers have fallen back on using R values, but that these must be accompanied by other criteria. “R value is the common measure of performance assessment being requested by customers deploying thermal protection solutions, however it should be considered as only part of the story.”
He continued: “The R Value is a measure of a material’s ability to resist heat transfer by conduction, with the higher the number equating to more protection,” he says. “There are a number of risks with just using R values, including problems of confusing imperial units with International Standard of Units (SI) and also with the different test methods being used.”

However, Mr Valentine says the key issue is that thermal covers are designed to protect against three sources of heat exchange, radiation, convection and conduction, with R values only measuring the latter.

“R values do not take into consideration the importance of both convection and radiation, which specifically relates to potential breaks within controlled distribution lanes,” he says.

“Exposure to direct sunlight is a major source of radiated heat transfer and is a threat within any break in a controlled lane. It is not uncommon for the temperature in direct sunlight to be 15-20oC hotter than the ambient temperature within the shade. A break in a controlled lane on a warm summer’s day could see a pallet exposed to direct sunlight temperatures of 50-60oC, even in temperate regions. A thermal cover’s ability to reflect radiated heat is of major importance, as is its potential to emit heat, known as the emissivity value.”

Testing conditions can also play an enormous role in determining the ultimate R value, says Mr Valentine. “A material tested with a 25mm air gap between its surface layers and the testing device will show a higher R value in comparison to a material with no air gaps. Thermal conductivity of materials can also change at different temperatures. The R value of a material can differ by as much as 10% when tested at hot (above 25oC) or cold (below zero) temperatures. It is very important for specifiers to understand which method of test has been used.”

He concludes: “I would urge specifiers to look beyond R values during performance assessment. It is important to fully understand the limits of R values, the performance data being used and its origins, as part of the performance assessment and implementation of thermal protection products. This will help reduce risk and improve quality, whilst also reducing costs within the distribution of temperature sensitive pharmaceutical products.”